[Federal Register Volume 67, Number 32 (Friday, February 15, 2002)]
[Notices]
[Page 7201]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-3720]



[[Page 7201]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Inter Company Collaboration for AIDS Drug 
Development

    Notice is hereby given that, on November 8, 2001, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Inter Company Collaboration 
for AIDS Drug Development has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership status. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances.
    Specifically, AstraZeneca PLC, London, UNITED KINGDOM; and Sigma-
Tau S.p.A., Rome, ITALY are no longer parties to this venture. Although 
there are no other changes in the membership, collaboration member 
Bristol-Myers Squibb Company has acquired collaboration member DuPont 
Pharmaceuticals Company.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Inter Company Collaboration for AIDS 
Drug Development intends to file additional written notification 
disclosing all changes in membership.
    On May 27, 1993, Inter Company Collaboration for AIDS Drug 
Development filed its original notification pursuant to section 6(a) of 
the Act. The Department of Justice published a notice in the Federal 
Register pursuant to section 6(b) of the Act on July 6, 1993 (58 FR 
36223).
    The last notification was filed with the Department on March 6, 
2001. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on June 1, 2001 (66 FR 29835-02).

Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 02-3720 Filed 2-14-02; 8:45 am]
BILLING CODE 4410-11-M